Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof

MYPI2026002338A0Undetermined Publication Date: 2022-03-14REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026002338
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-14
Filing Date
2021-09-14
Publication Date
2022-03-14
Patent Text Reader

Abstract

Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1R). In certain embodiments, provided are peptidomimetic payloads and linker-payloads and methods of making same. More specifically, GLP1 peptidomimetics, antibody-drug conjugates, and compositions which comprise anti-GLP1R antibodies and GLP1 peptidomimetic payloads and methods of treating GLP1 Rassociated conditions are provided. (No suitable figure.)
Need to check novelty before this filing date? Find Prior Art